Apollo Endosurgery, Inc. Quarterly Interest Expense in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Apollo Endosurgery, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q4 2022.
  • Apollo Endosurgery, Inc. Interest Expense for the quarter ending December 31, 2022 was $1.09M, a 74.6% decline year-over-year.
  • Apollo Endosurgery, Inc. Interest Expense for the twelve months ending December 31, 2022 was $4.67M, a 43.8% decline year-over-year.
  • Apollo Endosurgery, Inc. annual Interest Expense for 2022 was $4.67M, a 43.8% decline from 2021.
  • Apollo Endosurgery, Inc. annual Interest Expense for 2021 was $8.32M, a 58.4% increase from 2020.
  • Apollo Endosurgery, Inc. annual Interest Expense for 2020 was $5.25M, a 29.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $4.67M $1.09M -$3.2M -74.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $7.87M $1.16M -$187K -13.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $8.06M $1.21M -$128K -9.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $8.19M $1.22M -$130K -9.62% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $8.32M $4.29M +$2.93M +216% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $5.38M $1.34M +$7K +0.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $5.38M $1.33M +$18K +1.37% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $5.36M $1.35M +$108K +8.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $5.25M $1.36M +$153K +12.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-22
Q3 2020 $5.1M $1.34M +$114K +9.34% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $4.98M $1.32M +$647K +96.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $4.34M $1.24M +$285K +29.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $4.05M $1.2M +$120K +11.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.93M $1.22M +$220K +22% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.71M $669K -$350K -34.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $4.06M $959K -$1K -0.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $4.06M $1.08M +$115K +11.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $3.95M $1M -$12K -1.19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $3.96M $1.02M -$27K -2.58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $3.99M $960K -$521K -35.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $4.51M $968K -$10.3M -91.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $14.8M $1.01M -$520K -33.9% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-11-13
Q2 2017 $15.3M $1.05M -$1.48M -58.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $16.8M $1.48M -$1.35M -47.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $18.2M $11.3M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $1.53M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $2.52M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $2.83M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.